An increased activity of the angiotensin-converting enzyme (ACE) that converts Angiotensin I (Ang I) to Angiotensin II (Ang II), together with enhanced vasoconstriction, has been reported in AD (Benigni et al., 2010). This evidence concerns the gene ACE and Alzheimer disease.